Nina is a founder and CEO of Avenna and Wellcode Life. She is working in close collaboration with leading scientists and professionals in the field of precision health & wellness. At her company Avenna, she is specialising in translation of precision medicine tools into clinical practice for Inflammatory conditions.
Nina started her career in the City of London and worked at large corporations such as Schlumberger, Bloomberg, Nomura as well as multifamily offices.
In the last five years her focus was on preventative healthcare and transnational medicine. At her scientific wellness company Wellcode, she delivering personalised preventive health transformation programmes for corporate and individual clients.